Tianwei Xia1, Fei Yu2,3, Kaijia Zhang3, Zongfang Wu2,3, Dongquan Shi3, Huajian Teng4, Jirong Shen5, Xianfeng Yang6, Qing Jiang2,3. 1. The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210046, China. 2. Drum Tower of Clinical Medicine, Nanjing Medical University, Nanjing 210046, China. 3. Department of Sports Medicine and Adult Reconstructive Surgery, Drum Tower Hospital, School of Medicine, Nanjing University, Nanjing 210008, China. 4. Joint Research Center for Bone and Joint Disease, Model Animal Research Center (MARC), Nanjing University, Nanjing 210008, China. 5. Department of Orthopedics, Jiangsu Provincial Hospital of Traditional Chinese Medicine, Nanjing University of Chinese Medicine, Nanjing 210046, China. 6. Department of Radiology, Drum Tower Hospital, School of Medicine, Nanjing University, Nanjing 210008, China.
Abstract
BACKGROUND: Intraarticular injection of the mesenchymal stem cells (MSCs) has shown to be successful for treating osteoarthritis (OA). Nevertheless, many studies have been focusing on autologous MSCs. The following study investigates the safety and effectiveness of intraarticular injection of allogenic MSCs in a pig OA model. METHODS: Superparamagnetic iron oxide (SPIO) nanoparticles were labelled with bone marrow-derived mesenchymal stem cells (BM-MSCs) to allow cells tracking using magnetic resonance imaging (MRI). A pig OA model was established by bilateral medial meniscectomy. Next, SPIO-BM-MSCs were injected into the right knee, while the left knee was left untreated. MRI and radiography were used to assess the degree of OA and to evaluate the effectiveness of allogenic MSCs. Hematoxylin and eosin (H&E), safranin-o fast green staining, toluidine blue, and immunohistochemical staining were used to evaluate the therapeutic effect of the injections. RESULTS: At concentration of ≤20 µg/mL, SPIO caused no toxicity to BM-MSCs. Four weeks after surgery, OA changes were observed on MRI scan. The SPIO labeled BM-MSCs were found moving towards the impaired part of the cartilage 8 to 24 h after injections. In addition, no significant differences between the right side (therapeutic side) and the left side (untreated side) were observed following histological and immunohistochemistry analysis. CONCLUSIONS: The suitable concentration of SPIO for labelling BMSCs was 20 µg/mL, while the allogenic MSCs could move towards and accumulate around the impaired cartilage. No significant difference was found between treatment and control group.
BACKGROUND: Intraarticular injection of the mesenchymal stem cells (MSCs) has shown to be successful for treating osteoarthritis (OA). Nevertheless, many studies have been focusing on autologous MSCs. The following study investigates the safety and effectiveness of intraarticular injection of allogenic MSCs in a pig OA model. METHODS: Superparamagnetic iron oxide (SPIO) nanoparticles were labelled with bone marrow-derived mesenchymal stem cells (BM-MSCs) to allow cells tracking using magnetic resonance imaging (MRI). A pig OA model was established by bilateral medial meniscectomy. Next, SPIO-BM-MSCs were injected into the right knee, while the left knee was left untreated. MRI and radiography were used to assess the degree of OA and to evaluate the effectiveness of allogenic MSCs. Hematoxylin and eosin (H&E), safranin-o fast green staining, toluidine blue, and immunohistochemical staining were used to evaluate the therapeutic effect of the injections. RESULTS: At concentration of ≤20 µg/mL, SPIO caused no toxicity to BM-MSCs. Four weeks after surgery, OA changes were observed on MRI scan. The SPIO labeled BM-MSCs were found moving towards the impaired part of the cartilage 8 to 24 h after injections. In addition, no significant differences between the right side (therapeutic side) and the left side (untreated side) were observed following histological and immunohistochemistry analysis. CONCLUSIONS: The suitable concentration of SPIO for labelling BMSCs was 20 µg/mL, while the allogenic MSCs could move towards and accumulate around the impaired cartilage. No significant difference was found between treatment and control group.
Authors: Rahul Kumar Udehiya; H P Aithal; P Kinjavdekar; A M Pawde; Rajendra Singh; G Taru Sharma Journal: Res Vet Sci Date: 2013-02-13 Impact factor: 2.534
Authors: Raymundo Cruz; Carmen Ramírez; Oscar I Rojas; Oscar Casas-Mejía; Juan B Kouri; Marco A Vega-López Journal: Pathol Res Pract Date: 2015-07-21 Impact factor: 3.250
Authors: K P H Pritzker; S Gay; S A Jimenez; K Ostergaard; J-P Pelletier; P A Revell; D Salter; W B van den Berg Journal: Osteoarthritis Cartilage Date: 2005-10-19 Impact factor: 6.576
Authors: Ali S Arbab; Lindsey A Bashaw; Bradley R Miller; Elaine K Jordan; Jeff W M Bulte; Joseph A Frank Journal: Transplantation Date: 2003-10-15 Impact factor: 4.939
Authors: Caroline Hoemann; Rita Kandel; Sally Roberts; Daniel B F Saris; Laura Creemers; Pierre Mainil-Varlet; Stephane Méthot; Anthony P Hollander; Michael D Buschmann Journal: Cartilage Date: 2011-04 Impact factor: 4.634